Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia

Leukemia. 2008 Jul;22(7):1446-9. doi: 10.1038/sj.leu.2405077. Epub 2008 Jan 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / adverse effects*
  • Apoptosis
  • Bone Marrow / pathology
  • Bone Marrow / physiology*
  • Cytokines / biosynthesis
  • Female
  • Hematopoiesis*
  • Hematopoietic Stem Cells / physiology
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Lymphocyte Subsets / immunology*
  • Lymphoma / drug therapy*
  • Lymphoma / immunology
  • Lymphoma / pathology
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / pathology
  • Neutropenia / chemically induced*
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Cytokines
  • Rituximab